netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Results

Looking for Aflibercept found 9 matches

Formulary BNF Category
  Restricted Drug  Aflibercept  (Eylea) Subfoveal choroidal neovascularisation - 11.08.02
 
Non Formulary BNF Category
  Cytotoxic Drug Aflibercept  (Zaltrap) Cytotoxic drugs - 08.01


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Negative NICE TA 307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (08.01.05)
link in drug section NICE TA 486: Aflibercept for treating choroidal neovascularisation (11.08.02)
link in drug section NICE TA294: Macular degeneration (wet age-related) - aflibercept (11.08.02)
link in drug section NICE TA305: Macular oedema (retinal vein occlusion)- aflibercept (11.08.02)
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01)
link in drug section NICE TA346: Macular oedema (diabetic)- aflibercept (11.08.02)
link in drug section NICE TA409: Visual impairment caused by macular oedema after branch retinal vein occlusion- aflibercept.  (11.08.02)


 

netFormulary